Michael R Minogue bought $500K of Insulet (PODD)
Executed Feb 25, disclosed Feb 26, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Feb 26), the stock returned -12.7% (delay-adjusted); from the execution session (Feb 25), -11.7%. Derived: entry at the session's open, exit at the close 20 sessions later.
Michael R Minogue (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Insulet Corporation (PODD). Across 1 priced purchase filing, the average 21-session return was -11.7% from execution and -12.7% from disclosure (delay-adjusted; derived). The largest single filing was $500K of PODD (2,030 sh × $246.23, as filed), executed Feb 25.
Healthcare · Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United Sta…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→